ASX Announcement

FDA reaffirms positive benefit-risk of ACADIA's NUPLAZID

Published: 21/09/18, 10:52am (AEST)4 pages
Neuren Pharmaceuticals Limited
NEU:ASXHealthcare

Recent NEU Announcements

Price Sensitive only